SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-022855
Filing Date
2022-05-02
Accepted
2022-04-29 21:16:41
Documents
12
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2021_procapsgroup.htm 20-F 2771071
2 DESCRIPTION OF SECURITIES f20f2021ex2-5_procapsgroup.htm EX-2.5 34187
3 LIST OF SUBSIDIARIES f20f2021ex8-1_procapsgroup.htm EX-8.1 13106
4 CERTIFICATION f20f2021ex12-1_procapsgroup.htm EX-12.1 8734
5 CERTIFICATION f20f2021ex12-2_procapsgroup.htm EX-12.2 8756
6 CERTIFICATION f20f2021ex13-1_procapsgroup.htm EX-13.1 3995
7 CERTIFICATION f20f2021ex13-2_procapsgroup.htm EX-13.2 4509
8 GRAPHIC image_001.jpg GRAPHIC 23389
9 GRAPHIC image_002.jpg GRAPHIC 36484
10 GRAPHIC image_003.jpg GRAPHIC 55833
11 GRAPHIC fin_001.jpg GRAPHIC 8764
12 GRAPHIC fin_002.jpg GRAPHIC 2196
  Complete submission text file 0001213900-22-022855.txt   3020411
Mailing Address 9 RUE DE BITBOURG LUXEMBOURG N4 L-1273
Business Address 9 RUE DE BITBOURG LUXEMBOURG N4 L-1273 575-371-9280
Procaps Group, S.A. (Filer) CIK: 0001863362 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-40851 | Film No.: 22878811
SIC: 2834 Pharmaceutical Preparations